MENU
OMER
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Omeros (OMER) Earnings Date & Reports

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

OMER is expected to report earnings to rise 3.84% to -44 cents per share on November 05

Omeros OMER Stock Earnings Reports
Q3'25
Est.
$-0.45
Q2'25
Beat
by $0.03
Q4'24
Beat
by $0.15
Q3'24
Beat
by $0.13
Q2'24
Missed
by $0.27
The last earnings report on August 14 showed earnings per share of -43 cents, beating the estimate of -46 cents. With 503.31K shares outstanding, the current market capitalization sits at 283.11M.
View a ticker or compare two or three
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OMER showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com